Inventor · disambiguated record
David E. Anderson
Also filed as: ANDERSON DAVID · ANDERSON DAVID E · ANDERSON DAVID EVANDER
18 granted patents·21 pending applications·46 citations·filing 2002–2025
91Inventor score
Files withVARIATION BIOTECHNOLOGIES INC21ANDERSON DAVID E6BRIGHAM & WOMENS HOSPITAL2GLAXOSMITHKLINE BIOLOGICALS SA2BRIGHAM & WOMENS HOSPITAL INC1
Top patents by PatentIndex Score
39 records- 0192US11253587B2Vaccine compositions for the treatment of coronavirusVARIATION BIOTECHNOLOGIES INC·Filed 2021·Granted Feb 22, 2022·2 cites·20 claims
- 0291US9777043B2Compositions and methods for treatment of cytomegalovirusVARIATION BIOTECHNOLOGIES INC·Filed 2012·Granted Oct 3, 2017·17 cites·13 claims
- 0385US9833505B1Vaccine compositions for treatment of Zika virusVARIATION BIOTECHNOLOGIES INC·Filed 2017·Granted Dec 5, 2017·5 cites·17 claims
- 0482US11248026B2Compositions and methods for treatment of cytomegalovirusVARIATION BIOTECHNOLOGIES INC·Filed 2017·Granted Feb 15, 2022·2 cites·20 claims
- 0579US9610248B2Compositions and methods for treating influenzaANDERSON DAVID E·Filed 2011·Granted Apr 4, 2017·6 cites·63 claims
- 0677US9849173B2Methods for preparing vesicles and formulations produced therefromANDERSON DAVID E·Filed 2010·Granted Dec 26, 2017·5 cites·20 claims
- 0777US2025381266A1Immunotherapeutic compositions for treatment of glioblastoma multiformeVARIATION BIOTECHNOLOGIES INC·Filed 2024·Application pending·0 cites
- 0876US12421283B2Compositions and methods for treatment of cytomegalovirusVARIATION BIOTECHNOLOGIES INC·Filed 2022·Granted Sep 23, 2025·0 cites·17 claims
- 0975US2025269013A1Immunogenic compositions for treatment of hepatitis bBRII BIOSCIENCES LTD·Filed 2024·Application pending·0 cites
- 1074US2023221317A1Estimating cellular populationsMACFARLANE BURNET INSTITUTE FOR MEDICAL RES AND PUBLIC HEATH LIMITED·Filed 2022·Application pending·0 cites
- 1173US10736844B2Compositions and methods for treating viral infectionsANDERSON DAVID E·Filed 2012·Granted Aug 11, 2020·2 cites·8 claims
- 1273US9603920B2Compositions and methods for treating influenzaVARIATION BIOTECHNOLOGIES INC·Filed 2014·Granted Mar 28, 2017·3 cites·22 claims
- 1370US12128100B2Immunogenic compositions for treatment of Hepatitis BVARIATION BIOTECHNOLOGIES INC·Filed 2019·Granted Oct 29, 2024·0 cites·15 claims
- 1469US2023022956A1Immunotherapeutic compositionsGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2022·Application pending·0 cites
- 1568US8029797B2Multivalent HIV immunogenic compositions comprising a pool of lipidated and nonlipidated peptides representing Gag and Env variable regionsVARIATION BIOTECHNOLOGIES INC·Filed 2006·Granted Oct 4, 2011·2 cites·9 claims
- 1667US9907746B2Methods for preparing vesicles and formulations produced therefromANDERSON DAVID E·Filed 2010·Granted Mar 6, 2018·2 cites·9 claims
- 1764US2025258171A1Estimating cellular populationsMACFARLANE BURNET INSTITUTE FOR MEDICAL RES AND PUBLIC HEALTH LIMITED·Filed 2025·Application pending·0 cites
- 1862US11167033B2Compositions and methods for treating viral infectionsVARIATION BIOTECHNOLOGIES INC·Filed 2017·Granted Nov 9, 2021·0 cites·13 claims
- 1959US2019170749A1Estimating cellular populationsMACFARLANE BURNET INSTITUTE FOR MEDICAL RES AND PUBLI C HEALTH LIMITED·Filed 2017·Application pending·0 cites
- 2059US2020376113A1Immunotherapeutic compositions for treatment of glioblastoma multiformeVARIATION BIOTECHNOLOGIES INC·Filed 2020·Application pending·0 cites
- 2158US2011097418A1Compositions and methods for treating influenzaVARIATION BIOTECHNOLOGIES INC·Filed 2009·Application pending·0 cites
- 2258US2021069321A1Immunotherapeutic compositionsGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2020·Application pending·0 cites
- 2357US11167032B2Methods and compositions for therapeutic agentsVARIATION BIOTECHNOLOGIES INC·Filed 2018·Granted Nov 9, 2021·0 cites·8 claims
- 2457US2022233682A1Vaccine compositions for the treatment of coronavirusVARIATION BIOTECHNOLOGIES INC·Filed 2022·Application pending·0 cites
- 2555US10161010B2Methods for detection of anti-cytomegalovirus neutralizing antibodiesVARIATION BIOTECHNOLOGIES INC·Filed 2018·Granted Dec 25, 2018·0 cites·20 claims
- 2654US10456460B2Vaccine compositions for treatment of Zika virusVARIATION BIOTECHNOLOGIES INC·Filed 2017·Granted Oct 29, 2019·0 cites·18 claims
- 2754US2023149537A1Vaccines, adjuvants, and methods of generating an immune responseEISAI R&D MAN CO LTD·Filed 2021·Application pending·0 cites
- 2854US2024288440A1Methods and compositions based on longitudinal studiesMACFARLANE BURNET INSTITUTE FOR MEDICAL RES AND PUBLIC HEALTH·Filed 2021·Application pending·0 cites
- 2953US9732320B2Selective differentiation, identification, and modulation of human TH17 cellsBRIGHAM & WOMENS HOSPITAL INC·Filed 2014·Granted Aug 15, 2017·0 cites·1 claims
- 3052US2011177163A1Compositions and methods for treating hepatitis aVARIATION BIOTECHNOLOGIES INC·Filed 2009·Application pending·0 cites
- 3152US2015079077A1Methods and compositions for therapeutic agentsVARIATION BIOTECHNOLOGIES INC·Filed 2013·Application pending·0 cites
- 3252US2024123060A1Improved therapeutic composition comprising hepatitis b antigen having s, pre-s1 and pre-s2 protein, aluminium phosphate and interferon-alpha and use thereof for treatment of hepatitis bVARIATION BIOTECHNOLOGIES INC·Filed 2020·Application pending·0 cites
- 3351US10006096B2Methods for detection of anti-cytomegalovirus neutralizing antibodiesVARIATION BIOTECHNOLOGIES INC·Filed 2013·Granted Jun 26, 2018·0 cites·21 claims
- 3450US2015290306A1Compositions and methods for diagnosis and treatment of malignant gliomasANDERSON DAVID E·Filed 2013·Application pending·0 cites
- 3549US2014356399A1Compositions and methods for treating viral infectionsVARIATION BIOTECHNOLOGIES INC·Filed 2013·Application pending·0 cites
- 3648US2010061992A1Therapeutic uses of tim-3 modulatorsBRIGHAM & WOMENS HOSPITAL·Filed 2007·Application pending·0 cites
- 3744US2011245107A1Selective differentiation, identification, amd modulation of human th17 cellsBRIGHAM & WOMENS HOSPITAL·Filed 2009·Application pending·0 cites
- 3843US2004053324A1Assays and compositions for identifying agents that modulate the activity of deubiquitinating agentsFiled 2002·Application pending·0 cites
- 3931US2013323280A1Methods for preparing vesicles and formulations produced therefromANDERSON DAVID E·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David E. Anderson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →